Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New serotoninergic drugs from E. Merck

Nov. 29, 1996

Merck & Co. describes new compounds for dopamine-related disorders

Nov. 29, 1996

Zeneca submits antimigraine Rx for approval

Nov. 28, 1996

Novel anticonvulsant described by SmithKline Beecham

Nov. 28, 1996

First approval for Aricept

Nov. 27, 1996

Fujisawa antidementia agent in clinical stage

Nov. 27, 1996

Initial human safety studies completed for CoCensys' stroke drug

Nov. 27, 1996

Ebselen on track for NDA filing in Japan

Nov. 27, 1996

Clinical results reported for rhIGF-I in ALS patients

Nov. 27, 1996

New antioxidant from Shiseido shows CNS activity

Nov. 27, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...